BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 6976204)

  • 1. Purine deoxynucleoside toxicity in nondividing human lymphoid cells.
    Kefford RF; Fox RM
    Cancer Res; 1982 Jan; 42(1):324-30. PubMed ID: 6976204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purinogenic immunodeficiency diseases. Differential effects of deoxyadenosine and deoxyguanosine on DNA synthesis in human T lymphoblasts.
    Wilson JM; Mitchell BS; Daddona PE; Kelley WN
    J Clin Invest; 1979 Nov; 64(5):1475-84. PubMed ID: 115901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G1-phase arrest of cultured human leukemic T-cells induced by deoxyadenosine.
    Fox RM; Kefford RF; Tripp EH; Taylor IW
    Cancer Res; 1981 Dec; 41(12 Pt 1):5141-50. PubMed ID: 6272990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 2'-deoxycoformycin on the metabolism of purines and the survival of malignant cells in a patient with T-cell leukemia.
    Yu AL; Bakay B; Kung FH; Nyhan WL
    Cancer Res; 1981 Jul; 41(7):2677-82. PubMed ID: 6972800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deoxyadenosine metabolism and toxicity in cultured L5178Y cells.
    Lowe JK; Gowans B; Brox L
    Cancer Res; 1977 Sep; 37(9):3013-7. PubMed ID: 301772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of deoxyadenosine toxicity in hybrids between human T- and B- lymphoblasts as a model for the development of drug resistance in T-cell acute lymphoblastic leukemia.
    Kurtzberg J; Hershfield MS
    Cancer Res; 1985 Apr; 45(4):1579-86. PubMed ID: 3872167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of deoxynucleosides on cultured human leukemia cell growth and deoxynucleotide pools.
    Ross DD; Akman SA; Schrecker AW; Bachur NR
    Cancer Res; 1981 Nov; 41(11 Pt 1):4493-8. PubMed ID: 6975653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of RNA synthesis by deoxyadenosine plus deoxycoformycin in resting lymphocytes.
    Matsumoto SS; Yu J; Yu AL
    J Immunol; 1983 Dec; 131(6):2762-6. PubMed ID: 6196398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential production of deoxyadenosine by human T and B lymphoblasts.
    Iizasa T; Kubota M; Carson DA
    J Immunol; 1983 Oct; 131(4):1776-9. PubMed ID: 6352803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purine metabolizing enzymes as predictors of lymphoblast sensitivity to deoxyadenosine.
    Mitchell BS; Edwards NL
    J Lab Clin Med; 1984 Sep; 104(3):414-24. PubMed ID: 6147383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Terminal incorporation of 2'-deoxyadenosine into polyadenylate segments of polyadenylated RNA in G1-phase-arrested human T-lymphoblasts.
    Kefford RF; Fox RM; McCairns E; Fahey D; Muscat GE; Rowe PB
    Cancer Res; 1983 May; 43(5):2252-7. PubMed ID: 6187447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection by various deoxynucleosides against deoxyadenosine-induced DNA damage in adenosine deaminase-inactivated lymphocytes.
    Shimoyama RK; Seto S; Mori C
    Mol Genet Metab; 1999 Dec; 68(4):455-60. PubMed ID: 10607474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of DNA repair by deoxyadenosine in resting human lymphocytes.
    Seto S; Carrera CJ; Wasson DB; Carson DA
    J Immunol; 1986 Apr; 136(8):2839-43. PubMed ID: 2870121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deoxyadenosine triphosphate as a mediator of deoxyguanosine toxicity in cultured T lymphoblasts.
    Mann GJ; Fox RM
    J Clin Invest; 1986 Nov; 78(5):1261-9. PubMed ID: 3490493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible metabolic basis for the different immunodeficient states associated with genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase.
    Carson DA; Wasson DB; Lakow E; Kamatani N
    Proc Natl Acad Sci U S A; 1982 Jun; 79(12):3848-52. PubMed ID: 6808516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations induced at the hypoxanthine-guanine phosphoribosyltransferase locus of human T-lymphoblasts by perturbations of purine deoxyribonucleoside triphosphate pools.
    Mattano SS; Palella TD; Mitchell BS
    Cancer Res; 1990 Aug; 50(15):4566-71. PubMed ID: 2369732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deoxyribonucleoside triphosphate accumulation by leukemic cells.
    Mitchell BS; Edwards NL; Koller CA
    Blood; 1983 Aug; 62(2):419-24. PubMed ID: 6603241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of deoxycytidine kinase by deoxyadenosine: implications in deoxyadenosine-mediated cytotoxicity.
    Keszler G; Virga S; Spasokoukotskaja T; Bauer PI; Sasvari-Szekely M; Staub M
    Arch Biochem Biophys; 2005 Apr; 436(1):69-77. PubMed ID: 15752710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deoxycoformycin-induced response in chronic lymphocytic leukaemia: deoxyadenosine toxicity in non-replicating lymphocytes.
    Kefford RF; Fox RM
    Br J Haematol; 1982 Apr; 50(4):627-36. PubMed ID: 6978147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of deoxycytidine rescue of thymidine toxicity in human T-leukemic lymphocytes.
    Fox RM; Tripp EH; Tattersall MH
    Cancer Res; 1980 May; 40(5):1718-21. PubMed ID: 6989492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.